Cargando…
P645: IBRUTINIB FOR TREATMENT OF RELAPSED-REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: A MATCHING-ADJUSTED INDIRECT COMPARISON OF 3 RANDOMIZED PHASE 3 TRIALS
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429205/ http://dx.doi.org/10.1097/01.HS9.0000969484.78258.de |
| _version_ | 1785090652387672064 |
|---|---|
| author | Ghia, Paolo Munir, Talha Burger, Jan Seymour, John Rogers, Kerry Huang, Hsin-Hui Moreno, Carol Neumayr, Lynne Abbazio, Chris Sharman, Jeff |
| author_facet | Ghia, Paolo Munir, Talha Burger, Jan Seymour, John Rogers, Kerry Huang, Hsin-Hui Moreno, Carol Neumayr, Lynne Abbazio, Chris Sharman, Jeff |
| author_sort | Ghia, Paolo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429205 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104292052023-08-17 P645: IBRUTINIB FOR TREATMENT OF RELAPSED-REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: A MATCHING-ADJUSTED INDIRECT COMPARISON OF 3 RANDOMIZED PHASE 3 TRIALS Ghia, Paolo Munir, Talha Burger, Jan Seymour, John Rogers, Kerry Huang, Hsin-Hui Moreno, Carol Neumayr, Lynne Abbazio, Chris Sharman, Jeff Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429205/ http://dx.doi.org/10.1097/01.HS9.0000969484.78258.de Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Ghia, Paolo Munir, Talha Burger, Jan Seymour, John Rogers, Kerry Huang, Hsin-Hui Moreno, Carol Neumayr, Lynne Abbazio, Chris Sharman, Jeff P645: IBRUTINIB FOR TREATMENT OF RELAPSED-REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: A MATCHING-ADJUSTED INDIRECT COMPARISON OF 3 RANDOMIZED PHASE 3 TRIALS |
| title | P645: IBRUTINIB FOR TREATMENT OF RELAPSED-REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: A MATCHING-ADJUSTED INDIRECT COMPARISON OF 3 RANDOMIZED PHASE 3 TRIALS |
| title_full | P645: IBRUTINIB FOR TREATMENT OF RELAPSED-REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: A MATCHING-ADJUSTED INDIRECT COMPARISON OF 3 RANDOMIZED PHASE 3 TRIALS |
| title_fullStr | P645: IBRUTINIB FOR TREATMENT OF RELAPSED-REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: A MATCHING-ADJUSTED INDIRECT COMPARISON OF 3 RANDOMIZED PHASE 3 TRIALS |
| title_full_unstemmed | P645: IBRUTINIB FOR TREATMENT OF RELAPSED-REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: A MATCHING-ADJUSTED INDIRECT COMPARISON OF 3 RANDOMIZED PHASE 3 TRIALS |
| title_short | P645: IBRUTINIB FOR TREATMENT OF RELAPSED-REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: A MATCHING-ADJUSTED INDIRECT COMPARISON OF 3 RANDOMIZED PHASE 3 TRIALS |
| title_sort | p645: ibrutinib for treatment of relapsed-refractory chronic lymphocytic leukemia: a matching-adjusted indirect comparison of 3 randomized phase 3 trials |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429205/ http://dx.doi.org/10.1097/01.HS9.0000969484.78258.de |
| work_keys_str_mv | AT ghiapaolo p645ibrutinibfortreatmentofrelapsedrefractorychroniclymphocyticleukemiaamatchingadjustedindirectcomparisonof3randomizedphase3trials AT munirtalha p645ibrutinibfortreatmentofrelapsedrefractorychroniclymphocyticleukemiaamatchingadjustedindirectcomparisonof3randomizedphase3trials AT burgerjan p645ibrutinibfortreatmentofrelapsedrefractorychroniclymphocyticleukemiaamatchingadjustedindirectcomparisonof3randomizedphase3trials AT seymourjohn p645ibrutinibfortreatmentofrelapsedrefractorychroniclymphocyticleukemiaamatchingadjustedindirectcomparisonof3randomizedphase3trials AT rogerskerry p645ibrutinibfortreatmentofrelapsedrefractorychroniclymphocyticleukemiaamatchingadjustedindirectcomparisonof3randomizedphase3trials AT huanghsinhui p645ibrutinibfortreatmentofrelapsedrefractorychroniclymphocyticleukemiaamatchingadjustedindirectcomparisonof3randomizedphase3trials AT morenocarol p645ibrutinibfortreatmentofrelapsedrefractorychroniclymphocyticleukemiaamatchingadjustedindirectcomparisonof3randomizedphase3trials AT neumayrlynne p645ibrutinibfortreatmentofrelapsedrefractorychroniclymphocyticleukemiaamatchingadjustedindirectcomparisonof3randomizedphase3trials AT abbaziochris p645ibrutinibfortreatmentofrelapsedrefractorychroniclymphocyticleukemiaamatchingadjustedindirectcomparisonof3randomizedphase3trials AT sharmanjeff p645ibrutinibfortreatmentofrelapsedrefractorychroniclymphocyticleukemiaamatchingadjustedindirectcomparisonof3randomizedphase3trials |